导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 37.26% | 114/1050 |
| 近一周 | -0.06% | 296/1104 |
| 近一月 | -5.51% | 818/1103 |
| 近一季 | -10.83% | 742/1092 |
| 近半年 | 30.63% | 83/1070 |
| 近一年 | 45.78% | 99/1018 |
| 近两年 | 157.90% | 99/926 |
| 近三年 | 121.99% | 73/834 |
| 成立以来 | 265.10% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.54% 445/1070 |
72.33% 137/1101 |
- - |
- - |
| 2025 | 46.41% 235/1065 |
1.50% 682/1014 |
1.07% 608/1038 |
42.72% 147/1050 |
- 451/1065 |
| 2024 | 15.36% 164/1011 |
-3.90% 530/960 |
0.25% 290/983 |
16.69% 152/991 |
2.61% 215/1011 |
| 2023 | -9.42% 312/952 |
8.20% 165/880 |
-1.29% 251/895 |
-11.43% 647/915 |
-4.24% 426/952 |
| 2022 | -19.26% 303/867 |
-19.82% 509/773 |
7.07% 402/806 |
-10.42% 272/845 |
4.99% 207/867 |
| 2021 | 13.78% 199/740 |
-9.33% 473/580 |
27.93% 61/659 |
-4.15% 317/704 |
2.34% 341/740 |
| 2020 | 86.27% 71/554 |
13.21% 25/419 |
30.78% 119/466 |
8.62% 282/517 |
15.82% 186/554 |
| 2019 | 65.84% 52/410 |
35.15% 138/1146 |
-4.85% 697/1228 |
16.07% 33/390 |
11.11% 131/410 |
| 2018 | -19.04% 59/349 |
- - |
-5.59% 198/990 |
-8.72% 689/1000 |
-8.08% 156/1080 |
| 2017 | 1.73% 170/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 华夏创新前沿股票 VS. 东吴新产业精选股票A(580008) |